From November 28 to December 1, 2025, the “2025 International Conference on Precision Diagnosis and Treatment of Major Chronic Diseases, Biomedical Technology and Translational Medicine” was held in Xuzhou, Jiangsu Province. The conference was co-hosted by the Jiangsu Society of Pathophysiology, the School of Basic Medical Sciences of Xuzhou Medical University, the Department of Science and Technology of Xuzhou Medical University, and the Department of International Cooperation and Exchange of Xuzhou Medical University, with the Professional Committee of Systems Biomedicine of the Chinese Society of Pathophysiology and the Jiangsu Society of Physiological Sciences as co-organizers. Distinguished experts from institutions including the University of Surrey (UK), Peking University, Zhejiang University, Tongji University, Zhejiang Chinese Medical University and Tongji Hospital of Wuhan were invited as keynote speakers. Li Haiyang, Member of the Standing Committee of the University Party Committee and Vice President of Xuzhou Medical University, attended the conference, along with leaders of relevant university departments, young backbone teachers and graduate students.
At the opening ceremony, Li Haiyang delivered a welcome speech on behalf of the university, extending warm welcome to all participating experts. He pointed out that major chronic diseases are a common challenge to human health, and the innovation of precision diagnosis and treatment as well as the in-depth development of translational medicine are the key to addressing this challenge. He hoped that the conference would serve as a link to conduct in-depth discussions on the frontiers of major chronic disease mechanism research, precision intervention programs and biomedical technology translation, pool innovative forces through the integration of ideas, and also expected to take this opportunity to deepen exchanges and interactions with colleagues from all walks of life, and join hands to gather more wisdom for addressing the health challenges posed by major chronic diseases and building a strong defense for human health. The opening ceremony was hosted by Professor Song Yuanjian, Vice Dean of the School of Basic Medical Sciences.
Focusing on the cutting-edge hot topics of precision diagnosis and treatment of major chronic diseases, participating experts elaborated on the pathological mechanisms of renal fibrosis and tumor invasion, as well as the pathophysiological significance of specific tissues as sources of reactive oxygen species in the body, and explored the integrated traditional Chinese and Western medicine intervention strategies for immune response in myocardial infarction. Meanwhile, the conference also covered precision diagnosis and treatment technical tools such as AI- and gene fingerprint-based target prediction systems and molecular atlas construction of glomerular podocytes. These contents provided multi-dimensional support for the upgrading of precision diagnosis and treatment of major chronic diseases and the translation of biomedical technologies from multiple perspectives including mechanism research, intervention programs and technical support, triggering enthusiastic discussions among participants.
The conference also set up several sessions including the “Translational Medicine Forum”, “Biomedical Technology Forum” and “Graduate Student Forum”. Zou Quanli, Director of Shanghai Ugene Biotechnology Co., Ltd., as well as young scholars from Xuzhou Medical University, presented their innovative explorations in the field of major chronic disease research. In the Graduate Student Forum, nearly 10 doctoral and master's students from Sungkyunkwan University (South Korea) and Xuzhou Medical University reported their innovative research work in this field, demonstrating solid scientific research foundation and active academic thinking.
The successful holding of this conference not only provided a high-quality academic exchange platform for scholars at home and abroad, effectively promoted cooperative innovation in the field of precision diagnosis and treatment of major chronic diseases, but also gathered wisdom and consensus, injecting new vitality into the research on major chronic diseases.
(First Reviewer: Li Li. Second Reviewer: Song Yuanjian. Wenshi. Third Reviewer: Han Hongliu)
